药械指南

订阅

MedSci主页 / 所有栏目 / 药械指南

基于医院信息系统数据的临床用药风险自动监测评价专家共识

2021-10-25 中国研究型医院学会药物评价专业委员会 中国药物应用与监测

用药风险评价自动监测

随着药品不良反应(ADR)监测工作的深化,实施药物警戒、强化临床用药风险防控日趋重要。

中文标题：

基于医院信息系统数据的临床用药风险自动监测评价专家共识

发布机构：

中国研究型医院学会药物评价专业委员会

发布日期：

2021-10-25

简要介绍：

随着药品不良反应(ADR)监测工作的深化,实施药物警戒、强化临床用药风险防控日趋重要。利用信息化技术开展基于大样本住院人群真实世界数据(RWD)的ADR监测评价研究,能够高效、灵活、经济的为临床用药风险识别与管控提供精准依据。基于多年来临床用药风险自动监测评价工作的探索,我们邀请了医院药学、临床医学、药物警戒、药物流行病、信息技术等领域的专家,总结国内外相关研究进展与专家经验,对基于医院信息系统(HIS)数据的临床用药风险自动监测评价相关概念、基本原则、相关技术、研究方法、路线流程、应用前景等进行了全面阐述并形成《基于医院信息系统数据的临床用药风险自动监测评价专家共识》,旨在规范和普及相关专业人员的研究与实践,提升安全合理用药水平。 

相关资料下载：
[AttachmentFileName(sort=1, fileName=基于医院信息系统数据的临床用药风险自动监测评价专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=cade41c0023a906a, title=基于医院信息系统数据的临床用药风险自动监测评价专家共识, enTitle=, guiderFrom=中国药物应用与监测, authorId=0, author=, summary=随着药品不良反应(ADR)监测工作的深化,实施药物警戒、强化临床用药风险防控日趋重要。, cover=https://img.medsci.cn/202229/1644414853230_5579292.png, journalId=0, articlesId=null, associationId=2381, associationName=中国研究型医院学会药物评价专业委员会, associationIntro=中国研究型医院学会药物评价专业委员会, copyright=0, guiderPublishedTime=Mon Oct 25 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">随着药品不良反应(ADR)监测工作的深化,实施药物警戒、强化临床用药风险防控日趋重要。利用信息化技术开展基于大样本住院人群真实世界数据(RWD)的ADR监测评价研究,能够高效、灵活、经济的为临床用药风险识别与管控提供精准依据。基于多年来临床用药风险自动监测评价工作的探索,我们邀请了医院药学、临床医学、药物警戒、药物流行病、信息技术等领域的专家,总结国内外相关研究进展与专家经验,对基于医院信息系统(HIS)数据的临床用药风险自动监测评价相关概念、基本原则、相关技术、研究方法、路线流程、应用前景等进行了全面阐述并形成《基于医院信息系统数据的临床用药风险自动监测评价专家共识》,旨在规范和普及相关专业人员的研究与实践,提升安全合理用药水平。&nbsp;</span></p>, tagList=[TagDto(tagId=122725, tagName= 用药风险评价), TagDto(tagId=122726, tagName=自动监测)], categoryList=[CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=35, categoryName=预防公卫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10222, appHits=15, showAppHits=0, pcHits=426, showPcHits=10207, likes=0, shares=9, comments=7, approvalStatus=1, publishedTime=Fri Feb 11 15:49:00 CST 2022, publishedTimeString=2021-10-25, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Feb 09 21:58:22 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 08:51:38 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=基于医院信息系统数据的临床用药风险自动监测评价专家共识.pdf)])
基于医院信息系统数据的临床用药风险自动监测评价专家共识.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1200388, encodeId=56f2120038848, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adac6540604, createdName=sai00fuji, createdTime=Mon Mar 07 23:10:44 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196043, encodeId=56101196043eb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Tue Feb 22 13:04:36 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193661, encodeId=80a3119366179, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Tue Feb 15 17:34:58 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192869, encodeId=e5b51192869b5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Sun Feb 13 09:07:24 CST 2022, time=2022-02-13, status=1, ipAttribution=)]
    2022-03-07 sai00fuji

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1200388, encodeId=56f2120038848, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adac6540604, createdName=sai00fuji, createdTime=Mon Mar 07 23:10:44 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196043, encodeId=56101196043eb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Tue Feb 22 13:04:36 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193661, encodeId=80a3119366179, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Tue Feb 15 17:34:58 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192869, encodeId=e5b51192869b5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Sun Feb 13 09:07:24 CST 2022, time=2022-02-13, status=1, ipAttribution=)]
    2022-02-22 ms8000000018254969

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1200388, encodeId=56f2120038848, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adac6540604, createdName=sai00fuji, createdTime=Mon Mar 07 23:10:44 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196043, encodeId=56101196043eb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Tue Feb 22 13:04:36 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193661, encodeId=80a3119366179, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Tue Feb 15 17:34:58 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192869, encodeId=e5b51192869b5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Sun Feb 13 09:07:24 CST 2022, time=2022-02-13, status=1, ipAttribution=)]
    2022-02-15 ms8000000018254969

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1200388, encodeId=56f2120038848, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adac6540604, createdName=sai00fuji, createdTime=Mon Mar 07 23:10:44 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196043, encodeId=56101196043eb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Tue Feb 22 13:04:36 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193661, encodeId=80a3119366179, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Tue Feb 15 17:34:58 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192869, encodeId=e5b51192869b5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9be6495931, createdName=ms8000000018254969, createdTime=Sun Feb 13 09:07:24 CST 2022, time=2022-02-13, status=1, ipAttribution=)]
    2022-02-13 ms8000000018254969

    学习了

    0